Impaired microbicidal capacity of mononuclear phagocytes from ptients with type I Gaucher disease: Partial correction by enzyme replacement therapy

L. Máródi, Rita Káposzta, Judit Tóth, Aranka László

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The higher susceptibility to serious bacterial infections in patients with Gaucher disease (GD) may be due in part to defective function of phagocytic cells. We studied five patients with GD (type I) and examined the ability of granulocytes and mononuclear phagocytes from these patients to phagocytose and kill Staphylococcus aureus and to generate superoxide anion (O2-) on stimulation with fully opsonized bacteria. Serum-opsonized staphylococci were ingested equally by phagocytic cells from patients and controls. In the presence of normal serum, the extent of killing of S aureus and the release of O2- by granulocytes over incubation periods of 60 minutes and 30 minutes, respectively, were also equivalent for patients and controls. However, we found that killing of viable bacteria and release of O2- by the patients' monocytes was significantly lower than that in cells from controls (P <.05 for both). The magnitude of differences in killing and O2- release between patients' cells and those from controls was even more profound with monocyte-derived macrophages. Enzyme augmentation with macrophage-targeted glucocerebrosidase preparation for 6 months at doses from 7.5 to 10 U/kg/wk resulted in significant increases of functional activities and O2- generation of monocytes and macrophages along with hematologic and hepatosplenic improvements. These data suggest that mononuclear phagocytes from GD patients are defective in their ability to kill bacteria and to generate reactive oxygen intermediates. Our data also suggest that enzyme substitution may improve functions of monocytes and macrophages in patients with GD that should make them more resistant to severe bacterial infection.

Original languageEnglish
Pages (from-to)4645-4649
Number of pages5
JournalBlood
Volume86
Issue number12
Publication statusPublished - Dec 15 1995

Fingerprint

Enzyme Replacement Therapy
Gaucher Disease
Macrophages
Phagocytes
Bacteria
Enzymes
Glucosylceramidase
Monocytes
Superoxides
Bacterial Infections
Granulocytes
Substitution reactions
Oxygen
Serum
Staphylococcus
Phagocytosis
Staphylococcus aureus

ASJC Scopus subject areas

  • Hematology

Cite this

Impaired microbicidal capacity of mononuclear phagocytes from ptients with type I Gaucher disease : Partial correction by enzyme replacement therapy. / Máródi, L.; Káposzta, Rita; Tóth, Judit; László, Aranka.

In: Blood, Vol. 86, No. 12, 15.12.1995, p. 4645-4649.

Research output: Contribution to journalArticle

@article{645382dc891843b5bca2dc4afff719b6,
title = "Impaired microbicidal capacity of mononuclear phagocytes from ptients with type I Gaucher disease: Partial correction by enzyme replacement therapy",
abstract = "The higher susceptibility to serious bacterial infections in patients with Gaucher disease (GD) may be due in part to defective function of phagocytic cells. We studied five patients with GD (type I) and examined the ability of granulocytes and mononuclear phagocytes from these patients to phagocytose and kill Staphylococcus aureus and to generate superoxide anion (O2-) on stimulation with fully opsonized bacteria. Serum-opsonized staphylococci were ingested equally by phagocytic cells from patients and controls. In the presence of normal serum, the extent of killing of S aureus and the release of O2- by granulocytes over incubation periods of 60 minutes and 30 minutes, respectively, were also equivalent for patients and controls. However, we found that killing of viable bacteria and release of O2- by the patients' monocytes was significantly lower than that in cells from controls (P <.05 for both). The magnitude of differences in killing and O2- release between patients' cells and those from controls was even more profound with monocyte-derived macrophages. Enzyme augmentation with macrophage-targeted glucocerebrosidase preparation for 6 months at doses from 7.5 to 10 U/kg/wk resulted in significant increases of functional activities and O2- generation of monocytes and macrophages along with hematologic and hepatosplenic improvements. These data suggest that mononuclear phagocytes from GD patients are defective in their ability to kill bacteria and to generate reactive oxygen intermediates. Our data also suggest that enzyme substitution may improve functions of monocytes and macrophages in patients with GD that should make them more resistant to severe bacterial infection.",
author = "L. M{\'a}r{\'o}di and Rita K{\'a}poszta and Judit T{\'o}th and Aranka L{\'a}szl{\'o}",
year = "1995",
month = "12",
day = "15",
language = "English",
volume = "86",
pages = "4645--4649",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "12",

}

TY - JOUR

T1 - Impaired microbicidal capacity of mononuclear phagocytes from ptients with type I Gaucher disease

T2 - Partial correction by enzyme replacement therapy

AU - Máródi, L.

AU - Káposzta, Rita

AU - Tóth, Judit

AU - László, Aranka

PY - 1995/12/15

Y1 - 1995/12/15

N2 - The higher susceptibility to serious bacterial infections in patients with Gaucher disease (GD) may be due in part to defective function of phagocytic cells. We studied five patients with GD (type I) and examined the ability of granulocytes and mononuclear phagocytes from these patients to phagocytose and kill Staphylococcus aureus and to generate superoxide anion (O2-) on stimulation with fully opsonized bacteria. Serum-opsonized staphylococci were ingested equally by phagocytic cells from patients and controls. In the presence of normal serum, the extent of killing of S aureus and the release of O2- by granulocytes over incubation periods of 60 minutes and 30 minutes, respectively, were also equivalent for patients and controls. However, we found that killing of viable bacteria and release of O2- by the patients' monocytes was significantly lower than that in cells from controls (P <.05 for both). The magnitude of differences in killing and O2- release between patients' cells and those from controls was even more profound with monocyte-derived macrophages. Enzyme augmentation with macrophage-targeted glucocerebrosidase preparation for 6 months at doses from 7.5 to 10 U/kg/wk resulted in significant increases of functional activities and O2- generation of monocytes and macrophages along with hematologic and hepatosplenic improvements. These data suggest that mononuclear phagocytes from GD patients are defective in their ability to kill bacteria and to generate reactive oxygen intermediates. Our data also suggest that enzyme substitution may improve functions of monocytes and macrophages in patients with GD that should make them more resistant to severe bacterial infection.

AB - The higher susceptibility to serious bacterial infections in patients with Gaucher disease (GD) may be due in part to defective function of phagocytic cells. We studied five patients with GD (type I) and examined the ability of granulocytes and mononuclear phagocytes from these patients to phagocytose and kill Staphylococcus aureus and to generate superoxide anion (O2-) on stimulation with fully opsonized bacteria. Serum-opsonized staphylococci were ingested equally by phagocytic cells from patients and controls. In the presence of normal serum, the extent of killing of S aureus and the release of O2- by granulocytes over incubation periods of 60 minutes and 30 minutes, respectively, were also equivalent for patients and controls. However, we found that killing of viable bacteria and release of O2- by the patients' monocytes was significantly lower than that in cells from controls (P <.05 for both). The magnitude of differences in killing and O2- release between patients' cells and those from controls was even more profound with monocyte-derived macrophages. Enzyme augmentation with macrophage-targeted glucocerebrosidase preparation for 6 months at doses from 7.5 to 10 U/kg/wk resulted in significant increases of functional activities and O2- generation of monocytes and macrophages along with hematologic and hepatosplenic improvements. These data suggest that mononuclear phagocytes from GD patients are defective in their ability to kill bacteria and to generate reactive oxygen intermediates. Our data also suggest that enzyme substitution may improve functions of monocytes and macrophages in patients with GD that should make them more resistant to severe bacterial infection.

UR - http://www.scopus.com/inward/record.url?scp=0028885950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028885950&partnerID=8YFLogxK

M3 - Article

C2 - 8541556

AN - SCOPUS:0028885950

VL - 86

SP - 4645

EP - 4649

JO - Blood

JF - Blood

SN - 0006-4971

IS - 12

ER -